Published in J Immunol on July 15, 1998
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS One (2006) 1.68
Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci (2004) 1.11
Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J Immunol (2010) 1.06
Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4⁺ T-cell repertoire selection. Nat Commun (2012) 0.86
Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells. Int Immunol (2009) 0.85
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough. Front Immunol (2013) 0.84
Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection. Clin Exp Immunol (2003) 0.83
Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules. Protein Sci (2005) 0.81
The versatility of the αβ T-cell antigen receptor. Protein Sci (2014) 0.79
Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339. PLoS One (2012) 0.75
Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers. J Immunol (2015) 0.75
The nature of the isometric twitch. J Physiol (1921) 30.00
A new mathematical treatment of changes of ionic concentration in muscle and nerve under the action of electric currents, with a theory as to their mode of excitation. J Physiol (1910) 23.56
The heat-production in prolonged contractions of an isolated frog's muscle. J Physiol (1913) 23.23
The regulation of the supply of energy in muscular contraction. J Physiol (1921) 22.57
Length of muscle, and the heat and tension developed in an isometric contraction. J Physiol (1925) 19.20
The recovery heat-production in muscle. J Physiol (1922) 19.13
The four phases of heat-production of muscle. J Physiol (1920) 18.40
Repetitive stimulation by commutator and condenser. J Physiol (1934) 15.17
The absolute mechanical efficiency of the contraction of an isolated muscle. J Physiol (1913) 14.19
The relation of length to tension development and heat production on contraction in muscle. J Physiol (1914) 11.40
The anaerobic processes involved in muscular activity. J Physiol (1923) 11.31
The nature of oxyhaemoglobin, with a note on its molecular weight. J Physiol (1910) 10.05
A new form of differential micro-calorimeter, for the estimation of heat production in physiological, bacteriological, or ferment actions. J Physiol (1911) 8.14
The effect of frequency of excitation on the total electric response of medullated nerve. J Physiol (1935) 7.58
The effect of hydrogen-ion concentration on the recovery process in muscle. J Physiol (1924) 7.30
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
The effect of frequency of stimulation on the heat production of nerve. J Physiol (1927) 6.06
On the hydrogen-ion concentration and some related properties of normal human blood. J Physiol (1922) 5.20
Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med (2001) 5.06
Evolutionary relationships of human populations from an analysis of nuclear DNA polymorphisms. Nature (1986) 4.84
The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients. J Physiol (1909) 4.81
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
The maximum work and mechanical efficiency of human muscles, and their most economical speed. J Physiol (1922) 4.39
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
The heat production of muscles treated with caffein or subjected to prolonged discontinuous stimulation. J Physiol (1924) 4.33
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Electric excitation of the fin nerve of sepia. J Physiol (1935) 3.76
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis (2000) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
mtDNA control-region sequence variation suggests multiple independent origins of an "Asian-specific" 9-bp deletion in sub-Saharan Africans. Am J Hum Genet (1996) 2.79
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature (1986) 2.68
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
The Specific Electrical Resistance of Frog's Muscle. Biochem J (1921) 2.44
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun (2001) 2.31
Direct cloning of specific genomic DNA sequences in plasmid libraries following fragment enrichment. Nucleic Acids Res (1985) 2.27
Analysis of the human alpha-globin gene cluster reveals a highly informative genetic locus. Proc Natl Acad Sci U S A (1986) 2.26
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Vaccines against intracellular infections requiring cellular immunity. Nature (2000) 2.20
The heat-production and the mechanism of the veratrine contraction. J Physiol (1922) 2.11
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell (1990) 2.10
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet (1992) 2.09
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut (1989) 2.06
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut (2002) 2.00
Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99
The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol (1979) 1.98
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun (1998) 1.96
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
The genetics of inflammatory bowel disease. Gut (1997) 1.83
The pressure developed in muscle during contraction. J Physiol (1948) 1.81
The association of autoimmune disorders with inflammatory bowel disease. Q J Med (1989) 1.80
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis (2001) 1.79
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis (1999) 1.76
The analysis of galvanometer curves. J Physiol (1930) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Perianal Crohn's disease. Br J Surg (2004) 1.73
Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol Rev (1999) 1.72
Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet (1997) 1.71
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Crohn's disease and pregnancy. Gut (1984) 1.66
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis (1998) 1.66
An empirical exploration of the (delta mu)2 genetic distance for 213 human microsatellite markers. Am J Hum Genet (1999) 1.66
The heat-producton of surviving amphibian muscles, during rest, activity, and rigor. J Physiol (1912) 1.65
Role of the faecal stream in the maintenance of Crohn's colitis. Gut (1985) 1.63
A protein particle vaccine containing multiple malaria epitopes. Nat Biotechnol (1997) 1.61
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
The energy degraded in the recovery processes of stimulated muscles. J Physiol (1913) 1.60
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58